MINERALYS THERAPEUTICS, INC. (MLYS) Free cash flow 2023–2025
MINERALYS THERAPEUTICS, INC. (MLYS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$142.4MFY2025 · since FY2023: -$81.2M → -$142.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$142.4M | +14.4% |
| FY2024 | -$166.4M | -105.0% |
| FY2023 | -$81.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MLYS financial trends
MLYS RevenueMLYS Net incomeMLYS Net marginMLYS Gross profitMLYS Gross marginMLYS Operating incomeMLYS Operating marginMLYS Operating cash flowMLYS Capital expendituresMLYS Return on equityMLYS Stock buybacksMLYS Dividends paidMLYS Total assetsMLYS Total liabilitiesMLYS Shareholders’ equityMLYS overview →